Clovis Oncology Announces 2015 Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. ARM
3. FIS
4. BROS
5. EXPE
6. QCOM
7. MNTN
8. FICO
9. PAYC
10. APP

Go back to Clovis Oncology Announces 2015 Operating Results

Mizuho Securities Remains Sidelined on Clovis Oncology (CLVS) Ahead of ODAC Panel

February 29, 2016 7:45 AM EST

Mizuho Securities reiterated a Neutral rating on Clovis Oncology (NASDAQ: CLVS), and cut the price target to $21.00 (from $23.00), ahead of an ODAC Panel, scheduled for April 12th. Mizuho expects examination of dosing, response rates, patient characteristics and duration of therapy to be key... More

Clovis Oncology (CLVS) Misses Q4 EPS Views

February 25, 2016 4:15 PM EST

Clovis Oncology (NASDAQ: CLVS) reported Q4 EPS of ($3.12), $0.68 worse than the analyst estimate of ($2.44).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

... More